Legal & General Group’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
RI
OFM
CAC
LCM
CC
AG
Legal & General Group's IMUX Position: Q2 2022 in Review
Legal & General Group sold out of Immunic (IMUX) in Q2 2022, closing a stake of 151 shares — an estimated $17K sold.
Legal & General Group first reported a position in IMUX in Q2 2015 and held it in 24 quarters. The position peaked at $81K in Q2 2015. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.
- Legal & General Group reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
- Legal & General Group sold 151 Immunic shares in Q2 2022, an estimated $17K.
- Legal & General Group first reported a position in Immunic in Q2 2015 and held it in 24 quarters.
- Legal & General Group's Immunic position peaked at $81K in Q2 2015.
- 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.